PRISM MarketView

Clever Leaves Gains Exclusive License to Cultivate High Performance Cannabis

New York, February 15, 2024 - PRISM MarketView - As part of its partnership with award-winning Dutch seed bank, Paradise Seeds, global medicinal cannabis company, Clever Leaves Holdings (Nasdaq: CLVR), will develop and register high performance cannabis cultivars in Colo...

15 February 2024

Atara Biotherapeutics Files IND to Advance Lupus Treatment

New York, February 15, 2024 - PRISM MarketView - Atara Biotherapeutics (Nasdaq: ATRA) has submitted an Investigational New Drug (IND) application to the FDA for the use of ATA3219 as a monotherapy for the treatment of systemic lupus erythematosus(SLE) with kidney involve...

15 February 2024

Soluna Holdings Dives into AI Hosting with Strategic Co-location Partnership

New York, February 14, 2024 - PRISM MarketView - Soluna Holdings, Inc. (NASDAQ: SLNH), a pioneer in developing green data centers, has ventured into the AI hosting market through a landmark co-location agreement with a GPU startup specializing in AI computing. This partn...

14 February 2024

Inspira Technologies’ Stock Jumps Following First U.S. Patent for Blood Oxygenation System

New York, February 14, 2024 - PRISM MarketView - Inspira Technologies (Nasdaq: IINN), a pioneering medical technology company aiming to advance beyond traditional mechanical ventilators, has been granted the first-ever U.S. Patent for an orbiting blood oxygenation delive...

14 February 2024

Biotricity Expecting Record Margins for Q3

New York, February 14, 2024 - PRISM MarketView - Technology-as-a-Service company, Biotricity (Nasdaq: BTCY) expects to announce record margins and operational efficiency for the third quarter of fiscal year 2024. The company is expecting record gross margins of 73%, and ...

14 February 2024

Altimmune’s Stock Plummets Following Critical Short-Seller Analysis

New York, February 14, 2024 - PRISM MarketView - Altimmune’s (Nasdaq: ALT) shares plummeted by as much as 19% on Tuesday following the release of a critical analysis by short-seller Kerrisdale Capital Management, led by Sahm Adrangi. The report casts doubt on the potenti...

14 February 2024

PRISM EV Index Update: Beam Global Expands Federal Presence

New York, February 13, 2024 - PRISM MarketView - Beam Global (Nasdaq: BEEM), a sustainable infrastructure pioneer for transportation electrification and energy security, has made significant strides by securing first-time orders from six federal entities for its EV ARC™ ...

13 February 2024

PRISM Insight: Cannabis Stocks May Be Seeing Green During Marijuana Awareness Month as Investors Wait on DEA’s Rescheduling Decision

New York, February 13, 2024 - PRISM MarketView - Cannabis stocks are seeing a resurgence as investors await a decision from the DEA on potentially rescheduling marijuana. The AdvisorShares Pure US Cannabis ETF and other related ETFs have shown significant gains this year...

13 February 2024

Adverum Demonstrates “Sustained Disease Control” in Phase 2 Trial for Macular Degeneration

New York, February 13, 2024 - PRISM MarketView - Adverum Biotechnologies (Nasdaq: ADVM) has reported positive preliminary safety and efficacy data from a Phase 2 trial in patients with wet age-related macular degeneration (AMD) at the 47th Annual Meeting of the Macula So...

13 February 2024

FDA Fast Track for BioXcel’s Prostate Cancer Treatment

New York, February 13, 2024 - PRISM MarketView - Biopharmaceutical company, BioXcel Therapeutics, Inc. (Nasdaq: BTAI), has been granted FDA Fast Track designation for BXCL701 in combination with a CPI for the treatment of patients with metastatic small cell neuroendocrin...

13 February 2024